Steroids, hypertension and cardiac fibrosis
- PMID: 7582072
Steroids, hypertension and cardiac fibrosis
Abstract
Though we normally think of mineralocorticoid receptors as mediating aldosterone action on the kidney and other epithelia, the same receptors are found at comparable levels in non-epithelial tissues such as hippocampus and heart. In all tissues mineralocorticoid receptors have identical, high affinity for aldosterone, corticosterone and cortisol. In tissues such as the heart and hippocampus they are unprotected by the enzyme 11 beta hydroxysteroid dehydrogenase, which converts glucocorticoids to inactive 11-keto congeners; in such tissues mineralocorticoid receptors are thus overwhelmingly occupied by glucocorticoids, reflecting their much higher circulating levels. The epithelial effects of mineralocorticoid receptors and glucocorticoid receptors appear relatively uncomplicated, paralleling findings in cotransfection systems (corticosterone and cortisol, as well as aldosterone, are agonist in mineralocorticoid receptors; activated mineralocorticoid receptors and activated glucocorticoid receptors equivalently transactivate gene expression). In non-epithelial tissues, most notably the brain, the actions (and possible interactions) of mineralocorticoid receptors and glucocorticoid receptors appear much more complex, and are yet to be established in detail. We have recently confirmed and extended the findings of Weber and his colleagues that administration of aldosterone or deoxycorticosterone to uninephrectomized rates drinking 1% NaCl solution for 8 weeks is followed by interstitial and perivascular cardiac fibrosis. Whether or not the effect of corticosteroids on cardiac fibrosis reflects direct actions on cardiac muscle, or other cellular constituents of the heart, there appears to be significant interplay between mineralocorticoid receptors and glucocorticoid receptors, and possible roles for agonist and antagonist occupancy of both receptor types.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?J Hypertens. 2010 May;28(5):1044-53. doi: 10.1097/HJH.0b013e328335c381. J Hypertens. 2010. PMID: 20179635
-
Mineralocorticoid receptors, salt, and hypertension.Recent Prog Horm Res. 1997;52:247-60; discussion 261-2. Recent Prog Horm Res. 1997. PMID: 9238855 Review.
-
Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1629-38. Invest Ophthalmol Vis Sci. 2000. PMID: 10845579
-
Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.Mol Cell Endocrinol. 2006 Mar 27;248(1-2):79-86. doi: 10.1016/j.mce.2005.10.024. Epub 2005 Dec 5. Mol Cell Endocrinol. 2006. PMID: 16337083
-
Mineralocorticoid receptors and hypertension.J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):53-5. doi: 10.1016/0960-0760(95)00021-q. J Steroid Biochem Mol Biol. 1995. PMID: 7626506 Review.
Cited by
-
Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II.J Clin Invest. 2006 Sep;116(9):2403-12. doi: 10.1172/JCI27918. Epub 2006 Aug 17. J Clin Invest. 2006. PMID: 16917542 Free PMC article.
-
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.Hypertension. 2009 Dec;54(6):1313-20. doi: 10.1161/HYPERTENSIONAHA.109.140038. Epub 2009 Nov 2. Hypertension. 2009. PMID: 19884563 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical